Holen Sie sich die Stockscreener-App
3.18
1.60%
0.05
Dna X Inc Aktie (SONM) Neueste Nachrichten
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga
How DNA's Double Helix Structure Was Discovered - Encyclopedia Britannica
SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et
Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart
DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et
Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS
Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS
DNA X, Inc. announced that it expects to receive $4.999998 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
Applied DNA Sciences Named B2i Digital Featured Company to Share BNB-Focused Treasury Shift with Investors - The National Law Review
Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com
Price to book forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to earnings forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to sales forward of DNA X, Inc. – NASDAQ:SONM - TradingView
12 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
WhatsApp CEO Kunal Shah said Indians don’t value time. Sanskrit scholar responds - ThePrint
Enterprise value to revenue forward of DNA X, Inc. – MUN:J6P - TradingView
Alex Murdaugh defense points to unknown male DNA in push for new testing - 930 WFMD Free Talk
SONM Q3 2024 Earnings: Loss Narrows Significantly, Beats ExpectationsEarnings Miss Streak - newsline.com
Ginkgo Bioworks (DNA) director Henry Christian O receives 25,000 RSU equity grant - Stock Titan
[EFFECT] DNA X, Inc. SEC Filing - Stock Titan
DNA X | EFFECT: Others - Moomoo
DNA X Inc. (SONM) Faces Downside Pressure as Support Levels ApproachRVOL Spike - newsline.com
DNA X (SONM) deregisters 350M common shares tied to Chardan resale - Stock Titan
DNA Research Shows Your Muscles Remember How Strong and Fit You Once Were - inc.com
11 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session - Benzinga
DNA X, Inc. (formerly Sonim Technologies) Terminates Material Definitive Agreement – SEC Form 8-K Filing June 2026 - Minichart
Sonim Technologies Ends Major Equity Purchase Agreement - TipRanks
DNA X Ends $500 Million ChEF Equity Facility and Related Registration Rights With Chardan - TradingView
DNA X (NASDAQ: SONM) terminates $500M Chardan equity facility - Stock Titan
Natera Inc stock (US6323071042): insider sales and new oncology board appointments in focus - AD HOC NEWS
DNA X: Q1 Earnings Snapshot - AOL.com
Lotus Technology Inc. Unveils Eletre X: A Revolutionary Hybrid SUV Offering 1,200+ km Range and Supercar Performance Starting at €96,990 - Quiver Quantitative
12 Information Technology Stocks Moving In Tuesday's Intraday Session - Benzinga
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - Business Wire
SONMDNA X Inc Short Interest - Finviz
SONM Q3 2024 Earnings: EPS Surprises to the Upside with 22.76% Beat; Stock Rises 4%Preliminary Results - The Legal Advocate
SONM Q3 2024 Earnings: EPS Surprises Higher by 22.76%, Stock Rises Over 4%One-Time Gain Impact - The Legal Advocate
SONM Q3 2024 Earnings: EPS Beats Estimates by 22.76% Amid Cost DisciplineRetail Earnings Report - thelegaladvocate.com
DNA X Inc. (SONM) Shares Rise Nearly 6% as Buyer Interest Surges Near Key SupportBullish Sentiment - dars.gov.et
S&P 500 Edges Higher as Healthcare and Tech Rally Outweigh Utility DeclinePPI Inflation Report - thelegaladvocate.com
DNA X Inc. (SONM) Rallies 4.18% as Momentum Builds Toward Key ResistanceEntry Point Alerts - The Legal Advocate
DNA X, Inc. Enters Securities Purchase Agreement with DNA Holdings Venture, Inc. and Issues Convertible Note – Key Details and Terms - Minichart
DNA X Stock Looks at Nasdaq Deadline After Latest Financing - Bez Kabli
Sonim Technologies Faces Nasdaq Delisting After New Financing - TipRanks
DNA X Received Notice of Delisting - TradingView
CIA Accused of Searching Ancestry DNA for "Alien Genetics" - hypefresh.com
Why people are losing it over Ferrari’s first all-electric car - Fast Company
DNAGinkgo Bioworks Holdings Inc Stock Price and Quote - Finviz
DNA X, Inc. announced that it has received $3.052788 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
DNA X Inc. (SONM) Q3 2024 Earnings: EPS Beats Estimates, Stock Surges 13.71%Community Hot Stocks - Newser
8.40%
1.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):